Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

357.04B

Market cap357.04B

Price-Earnings ratio

117.92

Price-Earnings ratio117.92

Dividend yield

2.28%

Dividend yield2.28%

Average volume

8.58M

Average volume8.58M

High today

$148.89

High today$148.89

Low today

$144.10

Low today$144.10

Open price

$147.81

Open price$147.81

Volume

7.54M

Volume7.54M

52 Week high

$156.92

52 Week high$156.92

52 Week low

$77.58

52 Week low$77.58

Stock Snapshot

Merck(MRK) stock is priced at $144.64, giving the company a market capitalization of 357.04B. It carries a P/E multiple of 117.92 and pays a dividend yield of 2.28%.

On 2026-09-10, Merck(MRK) stock moved within a range of $144.10 to $148.89. With shares now at $144.64, the stock is trading +0.4% above its intraday low and -2.9% below the session's peak.

Trading volume for Merck(MRK) stock has reached 7.54M, versus its average volume of 8.58M.

The stock's 52-week range extends from a low of $77.58 to a high of $156.92.

MRK News

Simply Wall St 12h

Here's Why We're Wary Of Buying Merck's For Its Upcoming Dividend - simplywall.st

...

TipRanks 1d

Leerink ups Merck price target on pipeline momentum

Leerink analyst Daina Graybosch raised the firm’s price target on Merck (MRK) to $161 from $127 and keeps an Outperform rating on the shares. The firm cites Mer...

TipRanks 2d

Merck price target raised to $170 from $146 at Guggenheim

Guggenheim raised the firm’s price target on Merck (MRK) to $170 from $146 and keeps a Buy rating on the shares, driven mainly by increased sales estimates for...

Analyst ratings

68%

of 31 ratings

Buy

67.7%

Hold

29%

Sell

3.2%

More MRK News

Simply Wall St 6d

Merck, Why Is Its Latest Update Raising Bigger Questions?

Merck (MRK) is in focus after the FDA approved LIPFENDRA, the first oral PCSK9 inhibitor for hypercholesterolemia, while competitive pressure builds around its...

Simply Wall St 7d

Merck Stock Could Trade Below Fair Value Despite Rich Earnings

Merck stock has surged over recent years, yet the valuation signals are mixed, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to undervalua...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

WisdomTree Japan Hedged E…

Colgate

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.